1.70
price down icon2.30%   -0.04
pre-market  Vorhandelsmarkt:  1.67   -0.03   -1.76%
loading

Inflarx Nv Aktie (IFRX) Neueste Nachrichten

pulisher
Jul 27, 2026

InflaRx NV (IFRX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

InflaRx NV (IFRX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

InflaRx NV (IFRX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jul 27, 2026
pulisher
Jul 26, 2026

InflaRx N.V. Revenue Breakdown – SWB:IF0 - TradingView

Jul 26, 2026
pulisher
Jul 26, 2026

IFRX|InflaRx NV|Price:1.740|Chg%:+0.010 - TradingKey

Jul 26, 2026
pulisher
Jul 25, 2026

TradingKey - TradingKey

Jul 25, 2026
pulisher
Jul 25, 2026

InflaRx N.V. Revenue Breakdown – BOATS:IFRX - TradingView

Jul 25, 2026
pulisher
Jul 24, 2026

InflaRx NV (IFRX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jul 24, 2026
pulisher
Jul 18, 2026

InflaRx (IFRX) Under Pressure as Shares Slip 2.88% Toward Key SupportAlgorithmic Stock Picks - dars.gov.et

Jul 18, 2026
pulisher
Jul 17, 2026

IFRX Stock Price, Quote & Chart - ChartMill

Jul 17, 2026
pulisher
Jul 11, 2026

IFRX Q1 2026 Earnings: Narrower-than-Expected Loss on Stability, Stock EasesEarnings Call Q&A - DonanımHaber

Jul 11, 2026
pulisher
Jul 07, 2026

InflaRx NV focus on immune therapies as investors weigh long-term prospects - ad-hoc-news.de

Jul 07, 2026
pulisher
Jul 06, 2026

InflaRx N.V. (IFRX) Slips 1.79% as Stock Approaches Key Support LevelETF Premium Discount - DonanımHaber

Jul 06, 2026
pulisher
Jul 05, 2026

IFRX Q1 2026 Earnings: Surprise EPS Beat Despite Pre-Revenue StatusCapex Guidance - dars.gov.et

Jul 05, 2026
pulisher
Jul 04, 2026

Price to earnings forward of InflaRx N.V. – NASDAQ:IFRX - TradingView

Jul 04, 2026
pulisher
Jul 04, 2026

IFRXInflaRx NV Revenue Breakdown - Finviz

Jul 04, 2026
pulisher
Jul 01, 2026

Price to book forward of InflaRx N.V. – NASDAQ:IFRX - TradingView

Jul 01, 2026
pulisher
Jun 30, 2026

InflaRx Moves to Broaden AAV Strategy in Europe After EMA Setback for Tavneos - TipRanks

Jun 30, 2026
pulisher
Jun 30, 2026

InflaRx (IFRX) rethinks European AAV path after EMA Tavneos setback - Stock Titan

Jun 30, 2026
pulisher
Jun 30, 2026

InflaRx to explore regulatory path for AAV drugs in Europe - Investing.com

Jun 30, 2026
pulisher
Jun 30, 2026

InflaRx to explore regulatory path for AAV drugs in Europe By Investing.com - Investing.com South Africa

Jun 30, 2026
pulisher
Jun 30, 2026

InflaRx to Engage EMA on Vilobelimab and Izicopan Development Path in AAV - Quiver Quantitative

Jun 30, 2026
pulisher
Jun 30, 2026

InflaRx Assessing Feasibility of Broadened Strategy - One News Page

Jun 30, 2026
pulisher
Jun 30, 2026

symbol__ Stock Quote Price and Forecast - CNN

Jun 30, 2026
pulisher
Jun 29, 2026

Price to sales forward of InflaRx N.V. – NASDAQ:IFRX - TradingView

Jun 29, 2026
pulisher
Jun 29, 2026

Enterprise value to EBITDA forward of InflaRx N.V. – NASDAQ:IFRX - TradingView

Jun 29, 2026
pulisher
Jun 28, 2026

Price to earnings forward of InflaRx N.V. – GETTEX:IF0 - TradingView

Jun 28, 2026
pulisher
Jun 28, 2026

Price to sales forward of InflaRx N.V. – GETTEX:IF0 - TradingView

Jun 28, 2026
pulisher
Jun 28, 2026

Price to book forward of InflaRx N.V. – GETTEX:IF0 - TradingView

Jun 28, 2026
pulisher
Jun 28, 2026

Enterprise value to revenue forward of InflaRx N.V. – NASDAQ:IFRX - TradingView

Jun 28, 2026
pulisher
Jun 28, 2026

Enterprise value to EBIT forward of InflaRx N.V. – GETTEX:IF0 - TradingView

Jun 28, 2026
pulisher
Jun 27, 2026

ETFs Investing in InflaRx N.V. Stocks - TradingView

Jun 27, 2026
pulisher
Jun 25, 2026

InflaRx N.V. Actuals & Estimates (HAM:IF0) - TradingView

Jun 25, 2026
pulisher
Jun 25, 2026

InflaRx N.V. Actuals & Estimates (GETTEX:IF0) - TradingView

Jun 25, 2026
pulisher
Jun 25, 2026

IFRX Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026
pulisher
Jun 24, 2026

InflaRx NV (IFRX) Institutional Confidence - TradingKey

Jun 24, 2026
pulisher
Jun 23, 2026

InflaRx NV (IFRX) price target decreased by 16.67% to 7.29 - MSN

Jun 23, 2026
pulisher
Jun 22, 2026

InflaRx NV (IFRX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 22, 2026
pulisher
Jun 19, 2026

InflaRx N.V. (IFRX) Holds Near Support as Biotech Sentiment WeighsVolatility Breakout Picks - DonanımHaber

Jun 19, 2026
pulisher
Jun 18, 2026

InflaRx NV (IFRX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jun 18, 2026
pulisher
Jun 17, 2026

InflaRx NV (IFRX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

InflaRx StockAnalyst views and trading setup midweek - AD HOC NEWS

Jun 17, 2026
pulisher
Jun 17, 2026

InflaRx NV (IFRX) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jun 17, 2026
pulisher
Jun 16, 2026

IFRX Q1 2026 Earnings: Narrower-Than-Expected Loss Signals Cost Discipline, Though Stock DeclinesStrong Earnings Momentum - newsline.com

Jun 16, 2026
pulisher
Jun 14, 2026

InflaRx N.V. Q1 2026 Earnings: Narrower-than-Expected Loss Despite Stock DeclineEarnings Growth Forecast - newsline.com

Jun 14, 2026
pulisher
Jun 12, 2026

IFRX Q1 2026 Earnings: Narrower-than-Expected Loss Amid Clinical Progress; Stock SlipsPost-Announcement Reaction - newsline.com

Jun 12, 2026
pulisher
Jun 10, 2026

What Do Analysts Say About InflaRx N.V. (IFRX)? - Insider Monkey

Jun 10, 2026
pulisher
Jun 10, 2026

InflaRx N.V. (IFRX) Q1 2026 Earnings: EPS Exceeds Expectations as Drug Development Advances - newsline.com

Jun 10, 2026
pulisher
Jun 07, 2026

InflaRx N.V. (IFRX) Q4 2025 Earnings: Narrower-than-Expected Loss but Shares Slide 8%Buyback Announcement Report - dars.gov.et

Jun 07, 2026
pulisher
Jun 06, 2026

IFRX Q4 2025 Earnings: Narrower-than-Expected Loss Fails to Stem Stock DeclinePre-Earnings Drift - newsline.com

Jun 06, 2026
$91.09
price up icon 1.97%
$118.87
price up icon 1.02%
$34.72
price down icon 0.83%
$58.73
price down icon 0.17%
ONC ONC
$325.90
price up icon 0.00%
$278.40
price up icon 2.44%
Kapitalisierung:     |  Volumen (24h):